Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
about
Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritisIL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in ratsThe role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.The interleukin-17 cytokine family: critical players in host defence and inflammatory diseasesStructure and signalling in the IL-17 receptor familyIL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathwaysIncreased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritisIncreased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytesCD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic diseaseEarly rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsPathophysiological roles for IL-18 in inflammatory arthritisIL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tailMolecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.Zingiber officinale: A Potential Plant against Rheumatoid Arthritis.Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritisSEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.Evidence for ligand-independent multimerization of the IL-17 receptor.SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.Lipid extract from hard-shelled mussel (Mytilus coruscus) improves clinical conditions of patients with rheumatoid arthritis: a randomized controlled trial.Integrative pathway-based approach for genome-wide association studies: identification of new pathways for rheumatoid arthritis and type 1 diabetesNew mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG miceBone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner.The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone lossAntibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.IL-17 promotes progression of cutaneous leishmaniasis in susceptible miceAn overview of IL-17 function and signaling.Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritisThe biological and clinical importance of the 'new generation' cytokines in rheumatic diseasesInterleukin-17 and systemic lupus erythematosus: current concepts.Th17 cytokines and arthritisRheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
P2860
Q21195672-3DAF6FDC-B3D3-4A37-8331-5C471EB3AD87Q24294661-954FEEC8-EBF7-425C-82F3-B999769BCA72Q24519770-53423260-857F-4ED5-B944-6177A7A69E8AQ24594675-43FB7C79-65B2-412F-B6AD-A6B65A16EA18Q24648045-F7427A22-CAB0-40C1-B264-89530D62235FQ24793443-0D894BE2-B541-4E33-923D-00CF213BE413Q24799278-01C2D00F-0466-4E4B-A026-3B5408FCEB0EQ24800545-8379B710-5B2F-4361-82CA-7DDD02D75214Q24805444-FD4FAC1B-A813-4962-A9FD-49F34C83AF1AQ24817058-72BC5CBC-BE74-49BE-BFAA-718209483F76Q26774681-F3435361-FE1D-4377-A659-1A3D7FCE2271Q26828486-C4C9FEC6-D4FD-4136-A0AC-25A799014B1DQ28187644-AE22B5CD-8DDD-41FB-9158-76D76A0AA9BCQ28506505-EDD97906-9BBA-43FD-A99D-21D3CAA4DC32Q30480303-D98B0BEA-A324-4679-BDE5-2C868FF79014Q33759109-1CCFE385-6D42-4610-A5FB-747F471EAFE4Q34224709-5C797D95-9BE3-4E83-94B3-DE3B0DAA1FC7Q34236471-48D64316-7D6F-4A8C-9D04-1E6FDBB6F7C8Q34279731-137D573D-7D78-4D97-942F-FA3F5A997BE0Q34619592-6455F66C-2BF2-4721-9DDC-3AC75EC4E38BQ35003879-D2568FD1-7160-43C9-BFF2-03C34DAB17CDQ35036555-3CDBE19D-D7A1-4353-92DF-306DE9700B32Q35057902-AD253CC2-B40E-4A7E-A172-BE9FCE5886D0Q35557836-8D46579D-3202-475D-8053-2C0E06542D49Q35614331-02D25BD8-5773-4800-A57F-188484583DF1Q35804523-162E28F8-6C47-4B9A-91DB-DB463489912EQ36089312-8CE5FFA5-A133-44F2-8357-B140D0DDA062Q36295343-A5F22EAA-5185-49A2-82CA-DBCB35EF4ADEQ36747499-FA79D143-F060-47D4-A54F-3CB0E21EF229Q36806362-E087CE67-519C-4D06-AEB3-F3E71CDA07C8Q36845302-77A9DD3B-0E66-43BB-AFD5-E7C2F22BC020Q37111268-83611858-04D5-423C-913E-99E28B044741Q37135557-58B696A7-E984-49AF-8BF1-4E82DFB76351Q37243055-55C94A60-1423-4438-AB1B-23A91F18F693Q37286418-48E3E6CC-F020-4A31-B4FE-32C4138E0AAFQ37421251-2CA59E9A-6B41-4570-95D5-AA1EA0CF1F05Q37516563-A6CBEBC0-97AD-4091-ABF0-C7013DA386DFQ37552021-7581AFFE-102C-4EDB-982A-B4F2954F7421Q37686348-3C0BDCE3-63FC-48A7-B3B3-640092E5DA1EQ37690335-A0B4C2B3-D4A4-4496-B22F-014E15A4C276
P2860
Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@ast
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@en
type
label
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@ast
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@en
prefLabel
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@ast
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@en
P356
P1476
Interleukin-17 in rheumatoid a ...... d destruction through synergy.
@en
P304
P356
10.1002/ART.10816
P577
2003-03-01T00:00:00Z